The most promising derivatives for potent and preferred inhibitionagainst the target CAs II and VII over all other isoforms, after evaluationfor their stability in acidic media, were tested in a mouse modelof oxaliplatin-induced neuropathy. The gene discussed is CA2; the disease is neuropathy.